Tag Archives: House

Analysis looks at fiscal savings, human toll

By on .

Unless Congress finds ways to lower the federal deficit by $1.2 trillion in the next five months,  the law passed last year mandating across-the-board cuts to nearly all budget items will reduce current global health spending by about 10 percent of its current level, an analysis by the Foundation for AIDS Research (amfAR) estimates. The […]

Breaking News: Senate committee bumps up funding for NIH

By on .

On June 12, a Senate funding subcommittee voted on funding allocations for programs in health, human services, labor and education for the federal fiscal year beginning October 1, 2012.   Many details have not been released and more information will become available when the full Senate appropriations committee votes on the bill on Thursday, June 14.  […]

House Briefing Sheds Light On PEPFAR Policy Shift

By on .

At a Congressional briefing today, AIDS experts expressed grave concern about a shift in the focus of the US President’s Emergency Plan for AIDS Relief, from providing HIV treatment to patients to providing technical assistance to developing country governments. The policy shift comes hand-in-hand with a pull-back from funding targets authorized in the Lantos-Hyde Act, […]

Key Lawmakers Express Concern about US Global AIDS Funding

By on .

Five key House lawmakers—including the chair of the Congressional Black Caucus—have called on the Obama Administration to step up its commitment to combating global AIDS. In a letter to the president, Rep. Barbara Lee, D-Calif., and other House members expressed concerned that “continued rapid roll out of AIDS treatment is endangered in Africa” and said […]

Budget Deal Reached on Global Health Programs and Needle Exchange Ban

By on .

Lawmakers have finalized the fiscal year 2010 budget for foreign assistance, setting funding for key programs to fight global HIV and TB and reaching a landmark deal to revise the needle-exchange ban. The agreement—expected to pass the House before the end of this week and the Senate before the end of next week—includes some modest […]

An Easier Path to New TB Tools?

By on .

The search for new TB drugs and diagnostics is a long and windy road, paved with regulatory bumps and expensive R & D hurdles. But the path could get a little smoother under an amendment recently added to the Senate’s fiscal year 2010 funding bill for the Food and Drug Administration and other related programs. […]

Two Posts in One: Senate Leaves Needle Exchange Ban In Place, New Forum For HIV/AIDS Hot Topics

By on .

First, a quick update on needle exchange: The Senate Appropriations subcommittee on labor, health and education programs approved a spending bill this week that leaves in place the funding ban on needle exchange programs. This means a fight in conference over the fate of that provision, since the House approved language lifting the ban, albeit […]

Update: In U.S. House, A Win on Needle Exchange, A Loss on HIV Research

By on .

This is an update to our post earlier this morning on two key HIV policy votes in the House today. So much for a new era of evidence-based AIDS policy in a Congress controlled by Democrats. In today’s vote on HIV/AIDS research, lawmakers agreed (by voice vote) to strip out funding for three HIV research grants, […]

Two Vital HIV Policy Votes Set for U.S. House Today

By on .

The House of Representatives will take up two pivotal HIV/AIDS-related amendments today as it debates a massive spending bill for domestic labor, health and education programs. Although the policy decisions at stake today are part of a domestic funding bill, they have implications for global AIDS.  The first is a proposal by Rep. Darrell Issa, […]

House Panel Nixes Needle Exchange Ban, Senate Sets Funding for Global HIV/AIDS and TB

By on .

A key House subcommittee has called for lifting the ban on funding for needle-exchange programs, a significant step forward in the hard-fought battle for evidence-based treatment of HIV/AIDS. Disease experts, particularly those who specialize in treating HIV/AIDS, have long argued that the ban on needle exchange unnecessarily impeded HIV/AIDS prevention efforts. Rep. David Obey, D-Wis., […]